You are here: Home » News-IANS » Health-Medicine
Business Standard

A single protein may help treat Parkinson's, Alzheimer's

IANS  |  New York 

Scientists have found that a single protein can lead to effective treatments for devastating neurodegenerative diseases, such as Parkinson's, Huntington's, Alzheimer's and amyotrophic lateral sclerosis (ALS).

These disorders are triggered by misbehaving proteins in the brain that misfold and accumulate in neurons, inflicting damage and eventually killing the cells.

In the study, researchers from the Gladstone Institutes in California, used a different protein -- Nrf2 -- to restore levels of the disease-causing proteins to a normal, healthy range, thereby preventing cell death.

"We've tested Nrf2 in models of Huntington's disease, Parkinson's disease, and ALS, and it is the most protective thing we've ever found. Based on the magnitude and the breadth of the effect, we really want to understand Nrf2 and its role in protein regulation better," said Steven Finkbeiner from Gladstone Institute.

The researchers tested Nrf2 in two models of Parkinson's disease -- cells with mutations in the proteins LRRK2 and alpha-synuclein.

By activating Nrf2, the researchers turned on several "house-cleaning" mechanisms in the cell to remove excess LRRK2 and alpha-synuclein.

"Nrf2 coordinates a whole program of gene expression, but we didn't know how important it was for regulating protein levels until now," added Gaia Skibinski, research scientist at Gladstone Institute.

"Overexpressing Nrf2 in cellular models of Parkinson's disease resulted in a huge effect. In fact, it protects cells against the disease better than anything else we've found," Skibinski explained.

Using a one-of-a-kind robotic microscope, the team tagged and tracked individual neurons -- both rat and human -- over time to monitor their protein levels and overall health. They took thousands of images of the cells over the course of a week, measuring the development and demise of each one.

While, for mutant LRRK2, Nrf2 drove the protein to gather into incidental clumps that can remain in the cell without damaging it, for alpha-synuclein, Nrf2 accelerated the breakdown and clearance of the protein, reducing its levels in the cell, the results showed.

The study was published in the Proceedings of the National Academy of Sciences (PNAS).



(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, December 27 2016. 12:52 IST